Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GT Biopharma, Inc. has filed 875 SEC EDGAR filings since 12 May 1995

SEC filing history

Showing 226-250 of 516 matching filings.

Per page
25
Current page
10
CORRESP

CORRESP filing

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-251311

AMENDMENT NO 2

Filing date
08 Feb 2021
Reporting date
Not listed
Next action
Verify source filing
SC 13G/A File 005-32837

AMENDMENT NO. 5 TO SCHEDULE 13G

Filing date
05 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-251311

AMENDMENT NO 1

Filing date
02 Feb 2021
Reporting date
Not listed
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
02 Feb 2021
Reporting date
31 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
19 Jan 2021
Reporting date
13 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-08092

PRIMARY DOCUMENT

Filing date
14 Jan 2021
Reporting date
30 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
31 Dec 2020
Reporting date
28 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-08092

PRE 14C

Filing date
30 Dec 2020
Reporting date
30 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
28 Dec 2020
Reporting date
22 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Dec 2020
Reporting date
21 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
23 Dec 2020
Reporting date
22 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Dec 2020
Reporting date
16 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
16 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Dec 2020
Reporting date
11 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-239858

424B3

Filing date
19 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
13 Nov 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
424B3 File 333-239858

PRIMARY DOCUMENT

Filing date
09 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
09 Nov 2020
Reporting date
06 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-239858

424B3

Filing date
04 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
04 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-239858

424B3

Filing date
07 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-08092

CURRENT REPORT

Filing date
06 Oct 2020
Reporting date
05 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-239858

424B3

Filing date
22 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .